Biao Ma, Walter Glaser, Dominique Ferrandon, Marina Marcet-Houben, Ken Haynes, Jessica Quintin, Ute Zeidler, Fabian Istel, Brendan P. Cormack, Ingrid E. Frohner, Sascha Brunke, Katja Seider, Christophe d'Enfert, Brian Green, Sophie Bachellier-Bassi, Lauren Ames, Steffen Rupp, Karl Kuchler, Ilse D. Jacobsen, Ekkehard Hiller, Helmut Jungwirth, Vitor Cabral, Michael Tscherner, Arnaud Firon, Tobias Schwarzmüller, Murielle Chauvel, Bernhard Hube, Toni Gabaldón, Publica, Medizinische Universität Wien = Medical University of Vienna, Johns Hopkins University School of Medicine [Baltimore], Imperial College London, Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB), Center for sepsis control care, Friedrich Schiller University Jena [Jena, Germany], Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoell Institute), Friedrich-Schiller-Universität Jena, University of Exeter, Biologie et Pathogénicité fongiques, Institut National de la Recherche Agronomique (INRA)-Institut Pasteur [Paris], Cellule Pasteur UPMC, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut Pasteur [Paris], Centre for Genomic Regulation [Barcelona] (CRG), Universitat Pompeu Fabra [Barcelona]-Centro Nacional de Analisis Genomico [Barcelona] (CNAG), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut für Molekulare Biowissenschaften [Graz], Karl-Franzens-Universität Graz, This work was supported by the Austrian Science Foundation FWF through the ERA-Net Pathogenomics project FunPath to KK (FWF-API-0125), SR (BMBF: 0313931A), TG, CD, DF and BH, and in part by the Christian Doppler Society to KK. BC and BM were supported in part by NIH RO1AI46223. BH and SB were supported by the German Federal Ministry of Education and Research (BMBF) through FKZ: 01EO1002. TG was funded in part by grants from the Spanish ministry of science and innovation (GEN2006-27784E, BFU2009-09168). KH was funded by the BBSRC (BB/F005210/1). DF was also partly supported by CNRS and the Fondation pour la recherche Medicale (Programme Equipe FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., ANR-06-PATH-0005,FUNPATH,Genomic approaches to unravel the molecular mechanisms of pathogenicity in the human fungal pathogen candida glabrata(2006), Fraunhofer Institute for Interfacial Engineering and Biotechnology (Fraunhofer IGB), Fraunhofer (Fraunhofer-Gesellschaft), Friedrich-Schiller-Universität = Friedrich Schiller University Jena [Jena, Germany], Biologie et Pathogénicité fongiques (BPF), Institut National de la Recherche Agronomique (INRA)-Institut Pasteur [Paris] (IP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut Pasteur [Paris] (IP), Universitat Pompeu Fabra [Barcelona] (UPF)-Centro Nacional de Analisis Genomico [Barcelona] (CNAG), Institut Pasteur [Paris]-Institut National de la Recherche Agronomique (INRA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), lenormand, christelle, and Programme de recherche transnational Pathogenomics (ERA-NET) - Genomic approaches to unravel the molecular mechanisms of pathogenicity in the human fungal pathogen candida glabrata - - FUNPATH2006 - ANR-06-PATH-0005 - PATHO - VALID